Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Meng, Bo ^a   Ip, Natasha C Y ^a   Prestwood, Liam J ^a   Abbink, Truus E M ^a,b   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ESCRT; HIV; Late domain; Virus budding

Indexed keywords

ESCRT I PROTEIN; ESCRT II PROTEIN; ESCRT III PROTEIN; ESCRT PROTEIN; GAG PROTEIN; UNCLASSIFIED DRUG; PROTEIN BINDING; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS MUTANT; VIRUS RELEASE; CELL LINE; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BIOLOGICAL TRANSPORT; CELL LINE; CRISPR-CAS SYSTEMS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE KNOCKOUT TECHNIQUES; HIV-1; HUMANS; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; VIRION; VIRUS RELEASE;

EID: 84938942146     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0197-x     Document Type: Article

References (52)

1. Meng B, Lever AM (2013) Wrapping up the bad news: HIV assembly and release. Retrovirology 10:5
2. Fisher RD, Chung HY, Zhai Q, Robinson H, Sundquist WI, Hill CP (2007) Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128(5):841-852
3. Martin-Serrano J, Bieniasz PD (2003) A bipartite late-budding domain in human immunodeficiency virus type 1. J Virol 77(22):12373-12377
4. Fujii K, Munshi UM, Ablan SD, Demirov DG, Soheilian F, Nagashima K et al (2009) Functional role of Alix in HIV-1 replication. Virology 391(2):284-292
5. Babst M, Odorizzi G, Estepa EJ, Emr SD (2000) Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1(3):248-258
6. Hierro A, Sun J, Rusnak AS, Kim J, Prag G, Emr SD et al (2004) Structure of the ESCRT-II endosomal trafficking complex. Nature 431(7005):221-225
7. Im YJ, Hurley JH (2008) Integrated structural model and membrane targeting mechanism of the human ESCRT-II complex. Dev Cell 14(6):902-913
8. Teo H, Perisic O, Gonzalez B, Williams RL (2004) ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes. Dev Cell 7(4):559-569
9. Gill DJ, Teo H, Sun J, Perisic O, Veprintsev DB, Emr SD et al (2007) Structural insight into the ESCRT-I/-II link and its role in MVB trafficking. EMBO J 26(2):600-612
10. Teo H, Gill DJ, Sun J, Perisic O, Veprintsev DB, Vallis Y et al (2006) ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes. Cell 125(1):99-111
11. Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464(7290):864-869
12. Im YJ, Wollert T, Boura E, Hurley JH (2009) Structure and function of the ESCRT-II-III interface in multivesicular body biogenesis. Dev Cell 17(2):234-243
13. Teis D, Saksena S, Judson BL, Emr SD (2010) ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J 29(5):871-883
14. Langelier C, von Schwedler UK, Fisher RD, De Domenico I, White PL, Hill CP et al (2006) Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol 80(19):9465-9480
15. Pincetic A, Medina G, Carter C, Leis J (2008) Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J Biol Chem 283(44):29822-29830
16. Carlson LA, Hurley JH (2012) In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc Natl Acad Sci USA 109(42):16928-16933
17. Carlton JG, Martin-Serrano J (2007) Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316(5833):1908-1912
18. Goliand I, Nachmias D, Gershony O, Elia N (2014) Inhibition of ESCRT-II-CHMP6 interactions impedes cytokinetic abscission and leads to cell death. Mol Biol Cell 25(23):3740-3748
19. Malerod L, Stuffers S, Brech A, Stenmark H (2007) Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation. Traffic 8(11):1617-1629
20. Bowers K, Piper SC, Edeling MA, Gray SR, Owen DJ, Lehner PJ et al (2006) Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J Biol Chem 281(8):5094-5105
21. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT (2004) Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119(3):381-392
22. Slagsvold T, Aasland R, Hirano S, Bache KG, Raiborg C, Trambaiolo D et al (2005) Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting GLUE domain. J Biol Chem 280(20):19600-19606
23. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 88(8):3195-3199
24. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI (2003) Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77(9):5439-5450
25. Demirov DG, Ono A, Orenstein JM, Freed EO (2002) Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci USA 99(2):955-960
26. Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC et al (2008) Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe 4(6):592-599
27. Dussupt V, Javid MP, Abou-Jaoude G, Jadwin JA, de La Cruz J, Nagashima K et al (2009) The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog 5(3):e1000339
28. Hurley JH, Hanson PI (2010) Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 11(8):556-566
29. Babst M, Katzmann DJ, Snyder WB, Wendland B, Emr SD (2002) Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev Cell 3(2):283-289
30. Van Engelenburg SB, Shtengel G, Sengupta P, Waki K, Jarnik M, Ablan SD et al (2014) Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits. Science 343(6171):653-656
31. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI et al (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18(7):2569-2578
32. Freed EO (2003) The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol 11(2):56-59
33. Fujii K, Hurley JH, Freed EO (2007) Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat Rev Microbiol 5(12):912-916
34. Morita E, Sandrin V, McCullough J, Katsuyama A, Baci Hamilton I, Sundquist WI (2011) ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9(3):235-242
35. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM (2011) Dynamics of ESCRT protein recruitment during retroviral assembly. Nat Cell Biol 13(4):394-401
36. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP (2008) ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci USA 105(22):7687-7691
37. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114(6):689-699
38. Schmidt AE, Miller T, Schmidt SL, Shiekhattar R, Shilatifard A (1999) Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II. J Biol Chem 274(31):21981-21985
39. Jouvenet N, Bieniasz PD, Simon SM (2008) Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 454(7201):236-240
40. Ivanchenko S, Godinez WJ, Lampe M, Krausslich HG, Eils R, Rohr K et al (2009) Dynamics of HIV-1 assembly and release. PLoS Pathog 5(11):e1000652
41. Dussupt V, Sette P, Bello NF, Javid MP, Nagashima K, Bouamr F (2011) Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. J Virol 85(5):2304-2315
42. Tiwari RK, Kusari J, Sen GC (1987) Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO J 6(11):3373-3378
43. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72(4):2855-2864
44. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM et al (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46(6):1896-1905
45. Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F (1985) A molecular clone of HTLV-III with biological activity. Nature 316(6025):262-265
46. Richardson JH, Kaye JF, Child LA, Lever AM (1995) Helper virus-free transfer of human immunodeficiency virus type 1 vectors. J Gen Virol 76(Pt 3):691-696
47. Demirov DG, Orenstein JM, Freed EO (2002) The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J Virol 76(1):105-117
48. Peden K, Emerman M, Montagnier L (1991) Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185(2):661-672
49. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4(6):609-615
50. Lee Y, Park EJ, Yu SS, Kim DK, Kim S (2000) Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases. Biochem Biophys Res Commun 272(1):230-235
51. Abbink TE, Berkhout B (2008) RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. J Virol 82(6):3090-3098
52. L'Hernault A, Weiss EU, Greatorex JS, Lever AM (2012) HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses. J Virol 86(10):5867-5876